Mark D. Tattoli - 31 Dec 2023 Form 4 Insider Report for Core Laboratories Inc. /DE/ (CLB)

Role
SVP, Gen Counsel & Secretary
Signature
/s/ Mark D. Tattoli
Issuer symbol
CLB
Transactions as of
31 Dec 2023
Net transactions value
-$46,870
Form type
4
Filing time
03 Jan 2024, 17:50:15 UTC
Previous filing
04 Dec 2023
Next filing
15 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLB Common Stock Tax liability $46,870 -2,654 -20% $17.66 10,439 31 Dec 2023 Direct
transaction CLB Common Stock Options Exercise $0 +6,900 +111% $0.000000 13,093 31 Dec 2023 Direct
holding CLB Common Stock 20 31 Dec 2023 Custodial account
holding CLB Common Stock 1,695 31 Dec 2023 401 (k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLB Performance Shares Options Exercise $0 -6,900 -100% $0.000000* 0 29 Dec 2023 Common Stock 6,900 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were awarded as restricted performance shares in February 2021, as disclosed in the Reporting Person's Form 4A filing on October 6, 2021. All requirements for 100% vesting have been met and thus the restricted shares vested on December 31, 2023 at the conclusion of the performance period.